504 related articles for article (PubMed ID: 17000740)
1. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
Narcisi EM; Secor WE
Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
[TBL] [Abstract][Full Text] [Related]
3. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
4. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
Crowell AL; Sanders-Lewis KA; Secor WE
Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
[No Abstract] [Full Text] [Related]
6. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
Hager WD
Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
[TBL] [Abstract][Full Text] [Related]
8. Effects of metronidazole and tinidazole on NTPDase1 and ecto-5'-nucleotidase from intact cells of Trichomonas vaginalis.
Tasca T; Borges FP; Bonan CD; De Carli GA; Battastini AM; Sarkis JJ
FEMS Microbiol Lett; 2003 Sep; 226(2):379-84. PubMed ID: 14553936
[TBL] [Abstract][Full Text] [Related]
9. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
Sobel JD; Nyirjesy P; Brown W
Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole.
Biagi M; Slipke W; Smalley A; Tsaras G
Int J STD AIDS; 2021 Jan; 32(1):89-91. PubMed ID: 33121364
[TBL] [Abstract][Full Text] [Related]
11. [Antitrichomonal properties of derivatives of ethers containing amine and halogenarylalkyl groups].
Białasiewicz D; Kotełko B; Kurnatowska A; Kwaśniewska J
Wiad Parazytol; 1990; 36(5-6):281-5. PubMed ID: 2131703
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents.
Lövgren T; Salmela I
Acta Pathol Microbiol Scand B; 1978 Jun; 86B(3):155-8. PubMed ID: 102108
[TBL] [Abstract][Full Text] [Related]
13. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
[TBL] [Abstract][Full Text] [Related]
14. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
15. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
16. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
Mabaso N; Abbai N
Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.
Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE
J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968
[TBL] [Abstract][Full Text] [Related]
18. [Effect of tinidazole on T. vaginalis in vitro].
Savoia D; Martinetto P; Pugliese A
G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
[No Abstract] [Full Text] [Related]
19.
Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
[TBL] [Abstract][Full Text] [Related]
20. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
